SD

Stephen K. Doberstein

XE Xencor: 9 patents #22 of 104Top 25%
FT Five Prime Therapeutics: 7 patents #13 of 117Top 15%
EX Exelixis: 2 patents #132 of 312Top 45%
BS Bristol-Myers Squibb: 1 patents #2,477 of 3,969Top 65%
Overall (All Time): #222,289 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10183999 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2019-01-22
9714282 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2017-07-25
9192683 Methods of treating disease with FGFR1 fusion proteins Lewis T. Williams, Elizabeth Bosch, Kevin Hestir, Diane Hollenbaugh, Ernestine Lee +5 more 2015-11-24
9173957 FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIIC Lewis T. Williams, Elizabeth Bosch, Kevin Hestir, Diane Hollenbaugh, Ernestine Lee +5 more 2015-11-03
8858937 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2014-10-14
8809503 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2014-08-19
8580936 Polynucleotides encoding FGFR1-IIIc ECD fusion proteins Lewis T. Williams, Elizabeth Bosch, Kevin Hestir, Diane Hollenbaugh, Ernestine Lee +5 more 2013-11-12
8575312 Compositions and methods of use for MGD-CSF in disease treatment Dirk Behrens, Elizabeth Bosch, Robert F. Halenbeck, Kevin Hestir, Min Mei Huang +9 more 2013-11-05
8383109 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2013-02-26
8178109 Compositions and methods of use for MGD-CSF in disease treatment Dirk Behrens, Elizabeth Bosch, Robert F. Halenbeck, Kevin Hestir, Min Mei Huang +9 more 2012-05-15
8168588 Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions Lewis T. Williams, Hongbing Zhang, Yan Wang, Loriane Masuoka 2012-05-01
8093357 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2012-01-10
8039592 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2011-10-18
7982014 FGFR3-IIIc fusion proteins Lewis T. Williams, Elizabeth Bosch, Kevin Hestir, Diane Hollenbaugh, Ernestine Lee +5 more 2011-07-19
7846671 Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence Mark Ian Cockett, Chandra Ramanathan, Nicholas J. Lodge, Kevin Fitzgerald, Terry Stouch +3 more 2010-12-07
7662925 Optimized Fc variants and methods for their generation Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2010-02-16
7317091 Optimized Fc variants Gregory Alan Lazar, Arthur J. Chirino, Wei Dang, John Desjarlais, Robert Hayes +2 more 2008-01-08
6781028 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism Michael Costa, Sarah Elson, Kimberly Carr Ferguson, Sheila Akiko Homburger 2004-08-24
6627746 Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof Darren M. Platt, Kimberly Carr Ferguson, Andrew Roy Buchman, Sheila Akiko Homburger 2003-09-30
6468770 Nucleic acids and proteins of D. melanogaster insulin-like genes and uses thereof Linda Nolan Keyes, Andrew Roy Buchman, Bindu Priya Reddy, David Ruddy 2002-10-22